HomeBUSINESS
BUSINESS

Kyowa Kirin Pulls Plug on Tivantinib, Follows Daiichi Sankyo
(Oct.10.2017)

Kyowa Hakko Kirin said on October 6 that it has called off the development of the c-MET inhibitor tivantinib (ARQ197) after the company failed to yield positive results from any of its studies covering multiple tumor types ...
(LOG IN FOR FULL STORY)

News Calendar